MigVax Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $290K

  • Investors
  • 3

MigVax General Information

Description

Developer of vaccines intended to treat diseases including coronavirus and bird flu disease. The company's vaccines incorporates a chimeric protein to stimulate mucosal, systemic, and cell-mediated immune responses, delivered via a freeze-dried tablet that dissolves on the tongue without water, stable at room temperature for two months, and does not require healthcare professionals for administration, enabling medical practitioners to effectively tackle various diseases.

Contact Information

Website
www.migvax.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tarshish Street
  • Qiryat Shmona
  • Hazafon 11016
  • Israel
+972
Primary Industry
Drug Discovery
Corporate Office
  • Tarshish Street
  • Qiryat Shmona
  • Hazafon 11016
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MigVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Equity Crowdfunding 08-Nov-2022 $290K Completed Generating Revenue
2. Grant 04-Nov-2021 Completed Generating Revenue
1. Early Stage VC (Series A) 08-May-2020 $12M $12M Completed Generating Revenue
To view MigVax’s complete valuation and funding history, request access »

MigVax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A
To view MigVax’s complete cap table history, request access »

MigVax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vaccines intended to treat diseases including coronavirus and bird flu disease. The company's vaccines inco
Drug Discovery
Hazafon, Israel

Cambridge, MA

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MigVax Competitors (41)

One of MigVax’s 41 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Voyager Therapeutics Formerly VC-backed Lexington, MA
Baliopharm Venture Capital-Backed Basel, Switzerland
Gylden Pharma Venture Capital-Backed Abingdon, United Kingdom
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 41 competitors. Get the full list »

MigVax Patents

MigVax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4297777-A1 Oral compositions and use of same in vaccination Inactive 25-Feb-2021
EP-4297777-A4 Oral compositions and use of same in vaccination Inactive 25-Feb-2021
US-20240197864-A1 Oral compositions and use of same in vaccination Pending 25-Feb-2021
WO-2022180635-A1 Oral compositions and use of same in vaccination Inactive 25-Feb-2021 A61K9/0053

MigVax Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Coalition for Epidemic Preparedness Innovations Impact Investing
Happiness Capital Corporate Venture Capital Minority
OurCrowd Venture Capital Minority
To view MigVax’s complete investors history, request access »

MigVax FAQs

  • When was MigVax founded?

    MigVax was founded in 2020.

  • Where is MigVax headquartered?

    MigVax is headquartered in Hazafon, Israel.

  • What industry is MigVax in?

    MigVax’s primary industry is Drug Discovery.

  • Is MigVax a private or public company?

    MigVax is a Private company.

  • What is MigVax’s current revenue?

    The current revenue for MigVax is .

  • How much funding has MigVax raised over time?

    MigVax has raised $12.3M.

  • Who are MigVax’s investors?

    Coalition for Epidemic Preparedness Innovations, Happiness Capital, and OurCrowd have invested in MigVax.

  • Who are MigVax’s competitors?

    AnTolRx, Voyager Therapeutics, Baliopharm, Gylden Pharma, and Inovio Pharmaceuticals are some of the 41 competitors of MigVax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process